P501 Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02)
2017 ◽
Vol 11
(suppl_1)
◽
pp. S333-S334
Keyword(s):
Keyword(s):
2018 ◽
Vol 12
(supplement_1)
◽
pp. S314-S314
Keyword(s):
2016 ◽
Vol 61
(7)
◽
pp. 2060-2067
◽
Keyword(s):
P600 Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study from Finland
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S415-S416
Keyword(s):
2016 ◽
Vol 14
(2)
◽
pp. 20-28
◽
Keyword(s):
2015 ◽
Vol 148
(4)
◽
pp. S-22-S-23
◽
Keyword(s):
2017 ◽
Vol 11
(suppl_1)
◽
pp. S375-S375
Keyword(s):
2005 ◽
Vol 22
(5)
◽
pp. 453-461
◽
2018 ◽
Vol 1
(4)
◽
pp. 191-198
Keyword(s):